0000899243-19-027733.txt : 20191120 0000899243-19-027733.hdr.sgml : 20191120 20191120200240 ACCESSION NUMBER: 0000899243-19-027733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191118 FILED AS OF DATE: 20191120 DATE AS OF CHANGE: 20191120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weissman James B CENTRAL INDEX KEY: 0001598480 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 191235451 MAIL ADDRESS: STREET 1: C/O DICERNA PHARMACEUTICALS, INC. STREET 2: 33 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205993609 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 33 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-18 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001598480 Weissman James B C/O DICERNA PHARMACEUTICALS, INC. 33 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 EVP & Chief Operating Officer Common Stock 2019-11-18 4 M 0 20000 3.42 A 34704 D Common Stock 2019-11-18 4 S 0 20000 22.00 D 14704 D Common Stock 2019-11-19 4 M 0 20000 3.42 A 34704 D Common Stock 2019-11-19 4 S 0 20000 24.00 D 14704 D Employee Stock Option (Right to Buy) 3.42 2019-11-18 4 M 0 20000 0.00 D 2023-09-24 Common Stock 20000 20000 D Employee Stock Option (Right to Buy) 3.42 2019-11-19 4 M 0 20000 0.00 D 2023-09-24 Common Stock 20000 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2018. This option vested 1/48 monthly on the last day of each month with a vesting start date of 7/30/2013. /s/ John B. Green, attorney-in-fact 2019-11-20